201 related articles for article (PubMed ID: 36167770)
1. Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia.
Sales RR; Nogueira BL; Belisário AR; Faria G; Mendes F; Viana MB; Luizon MR
J Hum Genet; 2022 Dec; 67(12):701-709. PubMed ID: 36167770
[TBL] [Abstract][Full Text] [Related]
2. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
[TBL] [Abstract][Full Text] [Related]
3. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
[TBL] [Abstract][Full Text] [Related]
4. DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil.
Cardoso GL; Diniz IG; Silva AN; Cunha DA; Silva Junior JS; Uchôa CT; Santos SE; Trindade SM; Cardoso Mdo S; Guerreiro JF
Blood Cells Mol Dis; 2014 Dec; 53(4):176-9. PubMed ID: 25084696
[TBL] [Abstract][Full Text] [Related]
5. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
[TBL] [Abstract][Full Text] [Related]
6. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
[TBL] [Abstract][Full Text] [Related]
7. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans.
Akinsheye I; Solovieff N; Ngo D; Malek A; Sebastiani P; Steinberg MH; Chui DH
Am J Hematol; 2012 Feb; 87(2):217-9. PubMed ID: 22139998
[TBL] [Abstract][Full Text] [Related]
8. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
[TBL] [Abstract][Full Text] [Related]
9. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
[TBL] [Abstract][Full Text] [Related]
10. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.
Al-Allawi N; Qadir SMA; Puehringer H; Chui DHK; Farrell JJ; Oberkanins C
Int J Lab Hematol; 2019 Feb; 41(1):87-93. PubMed ID: 30216683
[TBL] [Abstract][Full Text] [Related]
11. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.
Sebastiani P; Farrell JJ; Alsultan A; Wang S; Edward HL; Shappell H; Bae H; Milton JN; Baldwin CT; Al-Rubaish AM; Naserullah Z; Al-Muhanna F; Alsuliman A; Patra PK; Farrer LA; Ngo D; Vathipadiekal V; Chui DH; Al-Ali AK; Steinberg MH
Blood Cells Mol Dis; 2015 Mar; 54(3):224-30. PubMed ID: 25703683
[TBL] [Abstract][Full Text] [Related]
12. Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype.
Ngo D; Bae H; Steinberg MH; Sebastiani P; Solovieff N; Baldwin CT; Melista E; Safaya S; Farrer LA; Al-Suliman AM; Albuali WH; Al Bagshi MH; Naserullah Z; Akinsheye I; Gallagher P; Luo HY; Chui DH; Farrell JJ; Al-Ali AK; Alsultan A
Blood Cells Mol Dis; 2013 Jun; 51(1):22-6. PubMed ID: 23465615
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
[TBL] [Abstract][Full Text] [Related]
14. High fetal hemoglobin level is associated with increased risk of cerebral vasculopathy in children with sickle cell disease in Mayotte.
Chamouine A; Saandi T; Muszlak M; Larmaraud J; Lambrecht L; Poisson J; Balicchi J; Pissard S; Elenga N
BMC Pediatr; 2020 Jun; 20(1):302. PubMed ID: 32563256
[TBL] [Abstract][Full Text] [Related]
15. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
16. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
Allard P; Alhaj N; Lobitz S; Cario H; Jarisch A; Grosse R; Oevermann L; Hakimeh D; Tagliaferri L; Kohne E; Kopp-Schneider A; Kulozik AE; Kunz JB
Haematologica; 2022 Jul; 107(7):1577-1588. PubMed ID: 34706496
[TBL] [Abstract][Full Text] [Related]
17. Genetics of fetal hemoglobin in tribal Indian patients with sickle cell anemia.
Bhanushali AA; Patra PK; Pradhan S; Khanka SS; Singh S; Das BR
Transl Res; 2015 Jun; 165(6):696-703. PubMed ID: 25651163
[TBL] [Abstract][Full Text] [Related]
18. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
[TBL] [Abstract][Full Text] [Related]
19. Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
Leonardo FC; Brugnerotto AF; Domingos IF; Fertrin KY; de Albuquerque DM; Bezerra MA; Araújo AS; Saad ST; Costa FF; Menzel S; Conran N; Thein SL
Br J Haematol; 2016 May; 173(3):456-60. PubMed ID: 26888013
[TBL] [Abstract][Full Text] [Related]
20. The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients.
Yang K; Wu Y; Ma Y; Xiao J; Zhou Y; Yin X
Blood Cells Mol Dis; 2020 Sep; 84():102442. PubMed ID: 32387854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]